$172.5 Million
Aligos Therapeutics
Initial Public Offering
Active Bookrunner
$229.0 Million
iTeos Therapeutics SA
Initial Public Offering
Active Bookrunner
$238.0 Million
Nurix Inc.
Initial Public Offering
Active Bookrunner
$128.0 Million
Inozyme Pharma, Inc.
Initial Public Offering
Active Bookrunner
$185.7 Million
ALX Oncology
Initial Public Offering
Active Bookrunner
$212.5 Million
Akouos, Inc.
Initial Public Offering
Active Bookrunner
$853.3 Million
American Well Corporation
Initial Public Offering
Active Bookrunner
$96.0 Million
Keros Therapeutics
Initial Public Offering
Active Bookrunner
$147.6 Million
Harmony Biosciences Holdings, Inc.
Initial Public Offering
Active Bookrunner
$103.5 Million
Graybug Vision, Inc.
Initial Public Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.